Gen QA

MEMBER LOGIN

MENU menu

Close close menu

Genomic EQA Directory

GenQA offer >120 genomics EQA covering thirteen different disciplines, encompassing the sample and patient journey. 

Free GenQA membership is required to purchase EQAs and enrol in individual competency assessments.

2025 EQA updates including 'early bird' EQA discounts.

 

2025 EQA price list (1st April 2025 - 31st March 2026)

 

GenQA LIVE calendar (includes EQA dates and other GenQA events)

Pharmacogenomics

Overview:

GenQA provides EQAs for individual genes and multi-gene NGS panel testing to reflect the variable approach to pharmacogenomic testing across the globe. These EQAs are available to all laboratories providing clinical testing for pharmacogenomic variants/alleles using any appropriate technology.

In conjunction with our expert advisors, we provide assessment of genotyping for all EQAs in addition to clinical interpretation where applicable.

 

Summary information:

Assess your testing and reporting of pharmacogenomic variants/alleles.

  • EQAs delivered in accordance with the international standard ISO 17043 for proficiency testing providers.
  • Any standard laboratory analysis methods
  • Cases based on real-world clinical scenarios, using validated samples.
  • 6 weeks to test samples and submit results
  • Submitted results are assessed by an expert scientific panel.
  • Each participant receives an Individual Laboratory Report (ILR) and EQA summary report detailing general findings, a summary of methodologies used, common errors and benchmarking against other laboratories worldwide.

Offers:

Enrol in one Pharmacogenomics EQA and get Pharmacogenomics panel EQA for free!

 

Pharmacogenomics: Aminoglycoside ototoxicity (PGXA)
Molecular testing of the MT-RNR1 gene.
Pharmacogenomics: APOE (pilot) (PGXE) NEW!
Molecular testing of the APOE gene.
Pharmacogenomics: CYP2C19 (pilot) (PGXC)
Molecular testing of the CYP2C19 gene.
Pharmacogenomics: DPYD (PGXD)
Molecular testing of the DPYD gene.
Pharmacogenomics: panel (pilot) (PGXP)
Molecular testing of variants in common pharmacogenetics genes.
Pharmacogenomics: TPMT and NUDT15 (PGXT)
Molecular testing of the TPMT and NUDT15 genes.